Number of the records: 1
homoharingtonín
SYS d000077863 LBL 00000nz--a2200181n--4500 005 20250606222657.2 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D03.132.420.500 065 $a D03.633.100.079.533.500 065 $a D03.633.400.624.500 066 $a 01 $c 03 150 $a homoharingtonín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a ceflatonín $2 slo 450 $w v $a cephalotaxín $2 slo 450 $w v $a homoharingtonín (3(R))-izomér $2 slo 450 $w v $a omacetaxín $2 slo 450 $w v $a omacetaxín mepesukcinát $2 slo 450 $w v $a Synribo $2 slo 550 $7 sllk_us_auth*d000972 $Y Antineoplastic Agents, Phytogenic $w P $a antineoplastiká fytogénne 550 $7 sllk_us_auth*d011500 $Y Protein Synthesis Inhibitors $w P $a inhibítory proteosyntézy 665 $a 2019 (1972) $2 eng 680 9-
$i Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC. $2 eng 750 -2
$a Homoharringtonine $2 eng 980 $x M
Number of the records: 1